These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8514332)

  • 1. Red-cell bound anti-A is more efficient than anti-B in competition for fluid phase complement.
    Bakács T; Tusnády G; Végh Z; Merry AH; Kertész Z; Klein E
    Immunol Lett; 1993 Mar; 35(3):213-7. PubMed ID: 8514332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions in the complement-mediated lysis of blood group AB erythrocytes sensitized simultaneously with anti-A and anti-B monoclonal antibodies.
    Bakács T; Végh Z; Merry AH; Sim RB; Varga L; Kertész Z; Tusnády G; Klein E
    Immunol Lett; 1993 Mar; 35(3):219-28. PubMed ID: 8514333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An indirect effect of an antibody on complement deposition and lysis of differently sensitized surrounding cells.
    Bakács T; Lutz HU; Tusnády G; Varga L; Merry AH; Sim RR
    Mol Immunol; 1994 Aug; 31(12):901-11. PubMed ID: 8065373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the competitive capacity of monoclonal antibody sensitized human A and B erythrocytes in complement mediated cytotoxicity.
    Bakács T; Ringwald G; Tusnády G; Végh Z; Klein E
    J Clin Lab Immunol; 1990 Aug; 32(4):167-75. PubMed ID: 1966933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of binding of C3 to IgG antibodies during the activation of the classical complement pathway on the red cell.
    Circolo A; Borsos T
    Mol Immunol; 1984 Mar; 21(3):191-5. PubMed ID: 6717444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of HIV-specific and 'antibody-independent' mechanisms for complement activation by HIV-infected cells.
    Saarloos MN; Lint TF; Spear GT
    Clin Exp Immunol; 1995 Feb; 99(2):189-95. PubMed ID: 7851010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential susceptibility of haemolysin-sensitized erythrocytes to complement-mediated cytotoxicity: a biological manifestation of the relationship between antibody availability and complement fixation.
    Bakács T; Ringwald G; Kimber I
    J Clin Lab Immunol; 1989 Oct; 30(2):61-7. PubMed ID: 2641530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complement-activating capacity of maternal IgG antibodies to blood group A in paired mother/child serum samples.
    Hari Y; von Allmen EC; Boss GM; Naiem A; Gittermann M; Nydegger UE
    Vox Sang; 1998; 74(2):95-100. PubMed ID: 9501407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.
    Bindon CI; Hale G; Brüggemann M; Waldmann H
    J Exp Med; 1988 Jul; 168(1):127-42. PubMed ID: 3260935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a C1q-ABO-ELISA to measure C1q binding by human anti-A alloantibodies.
    von Allmen E; Rieben R; Nydegger UE
    J Immunol Methods; 1994 May; 171(1):85-92. PubMed ID: 8176240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingomyelinases D induce direct association of C1q to the erythrocyte membrane causing complement mediated autologous haemolysis.
    Tambourgi DV; Pedrosa MF; de Andrade RM; Billington SJ; Griffiths M; van den Berg CW
    Mol Immunol; 2007 Jan; 44(4):576-82. PubMed ID: 16540172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of complement and specific antibodies with the external glycoprotein 120 of HIV-1.
    Prohászka Z; Hidvégi T; Ujhelyi E; Stoiber H; Dierich MP; Süsal C; Füst G
    Immunology; 1995 Jun; 85(2):184-9. PubMed ID: 7642209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C4 does not bind to human and rabbit IgM during activation of the classical complement pathway on the red cell.
    Circolo A; Borsos T
    J Immunol; 1982 Oct; 129(4):1485-8. PubMed ID: 7108214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation by cold agglutinins.
    Kirschfink M; Fritze H; Roelcke D
    Vox Sang; 1992; 63(3):220-6. PubMed ID: 1448966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of complement by bovine respiratory syncytial virus-infected cells.
    Kimman TG; Daha MR; Brinkhof JM; Westenbrink F
    Vet Immunol Immunopathol; 1989 Jul; 21(3-4):311-25. PubMed ID: 2800328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat polymeric IgA binds C1q, but does not activate C1.
    Hiemstra PS; Rits M; Gorter A; Stuurman ME; Hoekzema R; Bazin H; Vaerman JP; van Es LA; Daha MR
    Mol Immunol; 1990 Sep; 27(9):867-74. PubMed ID: 2215479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes.
    Parker CJ; Wiedmer T; Sims PJ; Rosse WF
    J Clin Invest; 1985 Jun; 75(6):2074-84. PubMed ID: 4008653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cold target competition analysis of the classical activation pathway of complement-mediated cytotoxicity: a non-interaction model for competing lysis.
    Tusnády G; Erdei A; Bakács T
    Mol Immunol; 1992 Nov; 29(11):1347-55. PubMed ID: 1406721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.